An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia. (NCT07033026)
A Phase 2, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of NGM120 in Participants With Colorectal Cancer Who Have Cancer Cachexia
🩺 Plain-English Summary (8th-Grade Level)
A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have cancer cachexia.
Who can join: Review the eligibility criteria below.
Location: NGM Clinical Study Site — Los Angeles, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (28 Sites)
Showing the first 25 of 28 sites.
- NGM Clinical Study Site — Los Angeles, California
- NGM Clinical Study Site — Los Angeles, California
- NGM Clinical Study Site — Santa Rosa, California
- NGM Clinical Study Site — Margate, Florida
- NGM Clinical Study Site — Baltimore, Maryland
- NGM Clinical Study Site — New York, New York
- NGM Clinical Study Site — Toledo, Ohio
- NGM Clinical Study Site — Youngstown, Ohio
- NGM Clinical Study Site — Dallas, Texas
- NGM Clinical Study Site — Kingwood, Texas
- NGM Clinical Study Site — Laredo, Texas
- NGM Clinical Study Site — Richmond, Virginia
- NGM Clinical Study Site — Appleton, Wisconsin
- NGM Clinical Study Site — Tbilisi,
- NGM Clinical Study Site — Tbilisi,
- NGM Clinical Study Site — Tbilisi,
- NGM Clinical Study Site — Tbilisi,
- NGM Clinical Study Site — Tbilisi,
- NGM Clinical Study Site — Goyang,
- NGM Clinical Study Site — Goyang,
- NGM Clinical Study Site — Incheon,
- NGM Clinical Study Site — Seoul,
- NGM Clinical Study Site — Seoul,
- NGM Clinical Study Site — Seoul,
- NGM Clinical Study Site — Suwon,
📞 Contact the Study Coordinator
Phone: (650) 727-8800
Email: NGM120CX@ngmbio.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colorectal Cancer
- Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes — Los Angeles, California
- A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors — Duarte, California
- Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) — Houston, Texas
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver — Basking Ridge, New Jersey
- The PRIME-CRC Trial to Promote CRC Screening in Rural Communities — Bastrop, Louisiana
- Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer — Concord, California
Explore by condition: All Colorectal Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.